Utilization of in vivo alkylated metabolites as a possible cause of increased sensitivity to tumor cells to alkylating agents.
D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000378:metabolism*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D007939:Leukemia L1210 / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008113:Liver Neoplasms; D008770:Methylnitrosourea / Q000378:metabolism*; D051379:Mice; D008815:Mice, Inbred Strains; D008970:Molecular Weight; D009363:Neoplasm Proteins / Q000096:biosynthesis; D009374:Neoplasms, Experimental / Q000378:metabolism; D009607:Nitrosourea Compounds / Q000378:metabolism*; D012334:RNA, Neoplasm / Q000096:biosynthesis; D013997:Time Factors
D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D009607:Nitrosourea Compounds; D012334:RNA, Neoplasm; D008770:Methylnitrosourea